Paragon 28

Registry records for this Colorado-registered Paragon 28 entity (registration number 20211941074) list five reporting institutional holders in a dataset dated 4 September 2026, out of 20 total holdings recorded in the underlying source: Fidelity Salem Street Trust – Fidelity Small Cap Index Fund (approximately 0.97%), iShares Trust – iShares Russell 2000 ETF (approximately 2.50%), Cadian Capital Management, LP (approximately 2.89%), AMG Funds – AMG GW&K Small Cap Value Fund (approximately 0.58%), and New York Life Investments ETF Trust – NYLI Merger Arbitrage ETF (approximately 0.46%). These are index and institutional fund positions consistent with reportable stakes in a NYSE-listed small-cap issuer.

This holder list corresponds to the period when Paragon 28, Inc. (ticker FNA) was independently listed on the New York Stock Exchange. It does not reflect current ownership. On 21 April 2025, Zimmer Biomet Holdings, Inc. completed the acquisition of Paragon 28, Inc. in an all-cash merger, executed through its subsidiary Zimmer, Inc. and a merger vehicle, Gazelle Merger Sub I, Inc., which merged with and into Paragon 28, Inc. Each outstanding share was converted into 13.00 US dollars in cash plus a contingent value right of up to 1.00 US dollar per share. Paragon 28 shares were delisted from the NYSE and Paragon 28 became a wholly owned subsidiary of Zimmer Biomet Holdings, Inc. Because the merger extinguished the prior public share register, the institutional holdings above should be read as historical rather than as this entity’s current shareholders.

Ultimate beneficial ownership

No individual ultimate beneficial owner is identified. Following the April 2025 merger, control rests with Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a publicly traded company with a dispersed shareholder base; no natural person is disclosed as holding a beneficial interest at a reportable threshold.

Data availability

Available information is Historical for the institutional holder register, which reflects the pre-merger public float, and Partial for current ownership: the change of control to Zimmer Biomet Holdings, Inc. is independently confirmed at the group level, but an entity-specific shareholder-of-record showing for registration number 20211941074 after the merger has not been independently verified.

Sources

Zimmer Biomet Holdings, Inc., Zimmer Biomet Completes Acquisition of Paragon 28, investor.zimmerbiomet.com, 21 April 2025; Paragon 28, Zimmer Biomet Completes Acquisition of Paragon 28, paragon28.com, 21 April 2025; PR Newswire, Zimmer Biomet Completes Acquisition of Paragon 28, 21 April 2025; Zimmer Biomet Holdings, Inc. Form 8-K, SEC EDGAR, April 2025. Retrieved 11 September 2026.

Registry records list five active officers or executives associated with this Paragon 28 entity, with no resignations or terminations recorded: Albert DaCosta (Co-founder, Chairman, President & CEO), Brendan Shook (Executive Vice President of Marketing & Medical Education, appointed 1 September 2019), Jeff Sears (Vice President of Operations, appointed 1 June 2022), Michelle Missal (Vice President & Chief Compliance Officer, appointed 1 February 2016), and Hans Kestler (Executive Vice President of International, appointed 1 July 2020). All five are recorded with a US correspondence country and an active work status as of the registry’s most recent sync, 9 September 2026.

Albert DaCosta’s role is independently confirmed: he co-founded the Paragon 28 business in 2010 and has served as its Chairman, President and Chief Executive Officer, a role referenced directly in Zimmer Biomet’s own announcements of its acquisition of Paragon 28. The remaining four officers are drawn from the registry’s officer disclosure and were not separately re-verified against an independent primary source for this profile; their titles and status should be read as reflecting the registry’s most recent snapshot rather than a re-confirmed current organisation chart.

Following Zimmer Biomet Holdings, Inc.’s completed acquisition of Paragon 28, Inc. on 21 April 2025, Paragon 28 operates as part of the Zimmer Biomet group. No independent public source confirming which named officers continued in these roles after integration into Zimmer Biomet was identified, so continued incumbency after that date should not be assumed from the appointment dates shown.

Data availability

Officer information is Partial: appointment dates are available for four of the five officers, but none of the five records disclose nationality, a full date of birth, or a country of residence distinct from the US correspondence address. Nationality is Not disclosed for all listed officers and must not be inferred from name or address.

Sources

Company registry officer disclosure, last synced 9 September 2026; Paragon 28 corporate leadership references in Zimmer Biomet Holdings, Inc., Zimmer Biomet Completes Acquisition of Paragon 28, investor.zimmerbiomet.com, 21 April 2025, and related orthopaedic industry coverage identifying Albert DaCosta as co-founder and CEO. Retrieved 11 September 2026.

This Colorado-registered Paragon 28 entity sits within the Zimmer Biomet corporate group. On 21 April 2025, Zimmer Biomet Holdings, Inc. (NYSE: ZBH) completed an all-cash acquisition of Paragon 28, Inc., executed through its wholly owned subsidiary Zimmer, Inc. and a merger vehicle, Gazelle Merger Sub I, Inc., which merged with and into Paragon 28, Inc. Paragon 28 shares were delisted from the New York Stock Exchange and Paragon 28, Inc. continued as a wholly owned subsidiary within the Zimmer Biomet group. Zimmer Biomet Holdings, Inc. is accordingly the ultimate parent of the Paragon 28 business, with Zimmer, Inc. sitting as an intermediate US holding company in the ownership chain.

The precise position of this specific Colorado registration (20211941074) within that structure, for example whether it is the entity directly acquired or a related US affiliate operating under the same Paragon 28 name, has not been independently confirmed beyond the registry’s own disclosure. Group-linkage data associated with this record also references a wider set of Paragon 28 operating companies in Ireland, Finland, the United Kingdom, Germany and Italy, and a large worldwide network of Zimmer Biomet subsidiaries; none of these additional entities could be independently verified against a primary filing for this profile, so they are not presented as confirmed relationships.

Verified corporate relationships

Recent structural changes

Acquisition: Zimmer Biomet Holdings, Inc. completed its acquisition of Paragon 28, Inc. on 21 April 2025, converting each Paragon 28 share into 13.00 US dollars in cash plus a contingent value right of up to 1.00 US dollar per share, and Paragon 28 became a wholly owned subsidiary of the Zimmer Biomet group.

Data availability

Parent-level information is Full and independently verified through official transaction announcements and SEC filings. Subsidiary-level information for this specific Colorado entity is Not found beyond the registry’s own group-linkage data, which was not independently corroborated for this profile.

Sources

Zimmer Biomet Holdings, Inc., Zimmer Biomet Completes Acquisition of Paragon 28, investor.zimmerbiomet.com, 21 April 2025; Paragon 28, Zimmer Biomet Completes Acquisition of Paragon 28, paragon28.com, 21 April 2025; PR Newswire, 21 April 2025; Zimmer Biomet Holdings, Inc. SEC filings referencing Zimmer, Inc. and Gazelle Merger Sub I, Inc. as merger parties. Retrieved 11 September 2026.